WisdomTree
Baoqi Zhu

Baoqi Zhu

Associate Director, Quantitative Research & Multi Asset Solutions

Baoqi Zhu joined WisdomTree in 2023 as a Senior Associate on the Research team. Baoqi focuses on quantitative research on thematic equity indices and portfolio solutions. Prior to WisdomTree, Baoqi spent over two years at Ernst & Young (EY) in their Quantitative Advisory Services, where he was involved in the research and development of quantitative risk models. Earlier in his career, Baoqi served as a quantitative analyst within a multi-asset structuring team at Maven Global for more than three years. His responsibilities included designing and optimising bespoke hedging strategies based on derivatives. Baoqi holds a MSc in Financial Engineering & Risk Management from Imperial College London and a BSc in Actuarial Science from Nankai University, China. He is also a certified Financial Risk Manager (FRM).

Latest insights from Baoqi Zhu

Japan’s Defense Sector Reaches an Inflection Point
Christopher Gannatti, CFA
Baoqi Zhu

Japan’s Defense Sector Reaches an Inflection Point

Japan reached its defense spending target two years ahead of schedule, and new taxes and export reforms could support a longer-lasting defense industry cycle. Christopher Gannatti and Baoqi Zhu examine what these policy and market changes could mean for Japanese defense companies and Asia-Pacific defense investing.

Read the article

Can the DeepSeek Wind Fill the Sails of Cloud Software Companies?
2024 Superconvergence BioRevolution Series: Training the Immune System to Fight Cancer - Cover Image
Christopher Gannatti, CFA
Elvira Kuramshina
Baoqi Zhu

Can the DeepSeek Wind Fill the Sails of Cloud Software Companies?

DeepSeek’s AI breakthroughs may be a game-changer for cloud software firms. By proving that AI models can be more cost-efficient and accessible, DeepSeek is lowering barriers for SaaS companies to integrate AI without squeezing margins. Chris Gannatti, Elvira Kuramshina and Baoqi Zhu examine how this could reshape the competitive landscape and accelerate AI adoption across the sector.

Read the article

China’s Third Plenum: Focus on Manufacturing and Very Short-Term Stimulus
2024 Superconvergence BioRevolution Series: Training the Immune System to Fight Cancer - Cover Image
Liqian Ren
Baoqi Zhu

China’s Third Plenum: Focus on Manufacturing and Very Short-Term Stimulus

China’s noteworthy Third Plenum focused on a short-term stimulus to meet this year’s growth target and stressed ongoing investment in manufacturing without introducing major new stimulus measures. Liqian Ren and Baoqi Zhu highlight potential opportunities in high-tech manufacturing sectors such as lithium-ion batteries. 

Read the article